Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Med Chem
2008 Jul 24;5114:4179-87. doi: 10.1021/jm800025e.
Show Gene links
Show Anatomy links
N-Hydroxypyrazolyl glycine derivatives as selective N-methyl-D-aspartic acid receptor ligands.
Clausen RP
,
Christensen C
,
Hansen KB
,
Greenwood JR
,
Jørgensen L
,
Micale N
,
Madsen JC
,
Nielsen B
,
Egebjerg J
,
Bräuner-Osborne H
,
Traynelis SF
,
Kristensen JL
.
???displayArticle.abstract???
A series of analogues based on N-hydroxypyrazole as a bioisostere for the distal carboxylate group of aspartate have been designed, synthesized, and pharmacologically characterized. Affinity studies on the major glutamate receptor subgroups show that these 4-substituted N-hydroxypyrazol-5-yl glycine (NHP5G) derivatives are selectively recognized by N-methyl- d-aspartic acid (NMDA) receptors and that the ( R)-enantiomers are preferred. Moreover, several of the compounds are able to discriminate between individual subtypes among the NMDA receptors, providing new pharmacological tools. For example, 4-propyl NHP5G is an antagonist at the NR1/NR2A subtype but an agonist at the NR1/NR2D subtype. Molecular docking studies indicate that the substituent protrudes into a region that may be further exploited to improve subtype selectivity, thereby opening up a design strategy for ligands which can differentiate individual NMDA receptor subtypes.
???displayArticle.pubmedLink???
18578474
???displayArticle.pmcLink???PMC4850074 ???displayArticle.link???J Med Chem ???displayArticle.grants???[+]
Akoka,
Concentration Measurement by Proton NMR Using the ERETIC Method.
1999, Pubmed
Akoka,
Concentration Measurement by Proton NMR Using the ERETIC Method.
1999,
Pubmed
Armstrong,
Structure of a glutamate-receptor ligand-binding core in complex with kainate.
1998,
Pubmed
Armstrong,
Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
2000,
Pubmed
Braitman,
Inhibition of [3H]kainic acid receptor binding by divalent cations correlates with ion affinity for the calcium channel.
1987,
Pubmed
Bräuner-Osborne,
Ligands for glutamate receptors: design and therapeutic prospects.
2000,
Pubmed
Christopoulos,
Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log.
1998,
Pubmed
Clausen,
The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
2004,
Pubmed
Dingledine,
The glutamate receptor ion channels.
1999,
Pubmed
Ebert,
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
1994,
Pubmed
Erreger,
Glutamate receptor gating.
2004,
Pubmed
Frandsen,
Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
2005,
Pubmed
,
Xenbase
Furukawa,
Subunit arrangement and function in NMDA receptors.
2005,
Pubmed
Furukawa,
Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
2003,
Pubmed
Halgren,
MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometries.
1999,
Pubmed
Halgren,
MMFF VI. MMFF94s option for energy minimization studies.
1999,
Pubmed
Hansen,
Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements.
2008,
Pubmed
,
Xenbase
Hansen,
Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis.
2005,
Pubmed
,
Xenbase
Hermit,
Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptors.
2004,
Pubmed
Honoré,
Complex structure of quisqualate-sensitive glutamate receptors in rat cortex.
1985,
Pubmed
Inanobe,
Mechanism of partial agonist action at the NR1 subunit of NMDA receptors.
2005,
Pubmed
,
Xenbase
Javitt,
Glutamate as a therapeutic target in psychiatric disorders.
2004,
Pubmed
Jin,
Structural basis for partial agonist action at ionotropic glutamate receptors.
2003,
Pubmed
,
Xenbase
Jørgensen,
Novel 5-substituted 1-pyrazolol analogues of ibotenic acid: synthesis and pharmacology at glutamate receptors.
2007,
Pubmed
Kinarsky,
Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket.
2005,
Pubmed
,
Xenbase
Mayer,
Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity.
2005,
Pubmed
Naur,
Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate.
2005,
Pubmed
Parsons,
Glutamate in CNS disorders as a target for drug development: an update.
1998,
Pubmed
Ransom,
Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines.
1988,
Pubmed
Riedel,
Glutamate receptor function in learning and memory.
2003,
Pubmed
Shinbo,
Chromatographic separation of racemic amino acids by use of chiral crown ether-coated reversed-phase packings.
1987,
Pubmed
Sills,
[3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
1991,
Pubmed
Traynelis,
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
1998,
Pubmed
,
Xenbase
